Summary.
An increased frequency of the A-allele of the α1-antichymotrypsin (ACT) gene has been recently described in Japanese patients suffering from Parkinson disease (PD). In the present study, we have analyzed 62 German PD patients with regard to their ACT and APOE genotypes and com-pared them to 53 controls without clinical or pathological evidence of neurodegenerative disease. The A-allele frequency was 47% in PD patients compared to 54% in control cases excluding ACT as a major susceptibility factor for PD in the Caucasian population. Yet, ACT-A allele frequencies were significantly different (p < 0.001) between Japanese and German controls. Therefore, although our data do not suggest that the α1-ACT polymorphism is a significant risk factor for the development of PD, a consideration of differences in genetic background seems warranted when evaluating susceptibility factors for neurodegenerative disease.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received September 24, 1998; accepted February 3, 1999
Rights and permissions
About this article
Cite this article
Grasbon-Frodl, E., Egensperger, R., Kösel, S. et al. The α1-antichymotrypsin A-allele in German Parkinson disease patients. J Neural Transm 106, 729–736 (1999). https://doi.org/10.1007/s007020050193
Issue Date:
DOI: https://doi.org/10.1007/s007020050193